Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Telemedicine · worldwide | Top 10 | #2 | Edition 0 (beta) · Sep 2026 | 2 Jan 2027 |
Estimated valuation
AI · Telemedicine ranking (worldwide)- Anchor
- Last known equity round: Equity round · USD 40M · Jun 2025
- Published valuation
- USD 4bn · Jun 2025
An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method
Funding history
| Date | Round | Amount | Type | Investors | Source |
|---|---|---|---|---|---|
| Jun 2025 | Equity round | USD 40M | Equity | General Catalyst | techcrunch.com |
Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Sword Health as a PDF, on one of three angles only:
Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.
Comparable companies in telemedicine
Full telemedicine ranking →Investors in Sword Health: General Catalyst
Sources. techcrunch.com · mobihealthnews.com
Last updated: Sep 2026Report an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.